Bruce Polsky, Director at Atea Pharmaceuticals, Inc. (AVIR), sold 35,088 shares at $3.49 ($122K) on 2024-06-20, disclosed to the SEC on 2024-06-21.
Open-market sale of $122k AVIR by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.49 | 17,544 | $61K | 50.0% |
| 2 | $3.49 | 17,544 | $61K | 50.0% |
| Total | $3.49 avg | 35,088 | $122K | 100% |